Navigation Links
International Conference on Biotherapy to be held in the US
Date:10/29/2010

The 8th International Conference on Biotherapy (ICB-2010) will be held in Los Angeles, November 11-14, 2010, at the Universal - Los Angeles Hilton. It is the single most important meeting for sharing new clinical and research findings in biotherapy (living organisms used to treat or diagnose illness). During the 4-day conference, an internationally distinguished faculty will educate clinicians and the public about maggot therapy, leech therapy (hirudotherapy), bee venom therapy, phage therapy, ichthyotherapy (the treatment of certain skin disorders with the help of specific fish), helminthic therapy for autoimmune disease, pet and hippotherapy, cancer-detecting dogs, and more.

Running jointly with the biotherapy conference, in the same conference center, will be the American Apitherapy Society's Annual Course and Conference (CMACC).

The International Conference on Biotherapy was planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Cincinnati, the BioTherapeutics & Research Foundation and the Hope of Healing Foundation. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians

The first two international conferences were held in Porthcawl, South Wales, UK in 1996 and 1997 under the name First and Second World Conference on Biosurgery. Subsequently, Israel, Germany, Turkey and South Korea hosted one or more of these international conferences. "The last International Conference was a great success," stated Dr. Kosta Mumcuoglu, Conference Co-Chair and President of the International Biotherapy Society (IBS). "The 7th ICB was held in Seoul and was attended by participants from nearly 20 countries."

"This is the first time that the International Conference is being held in the U.S.," notes Dr. Ronald Sherman, also Conference Co-Chair and Director of the BioTherapeutics, Education & Research (BTER) Foundation, one of the conference co-sponsors. "The BTER Foundation has been raising funds for years to produce high-quality educational programs like this. We are delighted to bring ICB-2010 to America, and bring Biotherapy to the next level." During the conference, both the IBS and the BTER Foundation will be holding their annual meetings. At its annual meeting, the BTER Foundation will be presenting its first William S. Baer Award for Outstanding Service for the Advancement of Biotherapy.

ICB-2010 will include general education sessions, presentations of cutting-edge research, and hands-on clinical training for therapists. According to Dr. Aletha Tippett, Conference Co-Chair and President of the co-sponsoring Hope for Healing Foundation, "we have already registered participants from across the globe - physicians, nurses and physical therapists, biologists and researchers, journalists and the general public." Unusual among clinical and research conferences is the fact that patients will also be lecturing about their experiences with biotherapy, and available to answer questions from faculty, attendees, and the media.

Two biotherapeutic modalities have already made their way into mainstream medicine: maggot therapy and leech therapy. Both organisms are produced according to Good Manufacturing Practices in FDA-regulated laboratories. Marketing clearance for manufacturers of medicinal maggots and leeches was granted in 2004. Clinical studies are underway to define the safety and efficacy of bee venom therapy, bacteriophage therapy, helminthic therapy and ichthyotherapy; updates on these and other treatments will be presented during the conference.


'/>"/>

Contact: Ronald Sherman
RSherman@BTERFoundation.org
949-679-3000
Monarch Labs
Source:Eurekalert  

Related biology news :

1. BIO-key(R) International To Exhibit at Oracle OpenWorld
2. Sentara begins international trial -- open at only 24 US locations
3. Perinatal Days and International Stillbirth Conference -- Nov.5-7
4. AVS 55th International Symposium & Exhibition, Oct. 19-24
5. Minnesota ecology professor wins international award for biodiversity and biofuels research
6. International Council for Science launches major research program on natural disasters
7. Innovations in Pediatric Medicine International Conference brings together pediatrics experts
8. International Journal of Social Robotics debuts at Springer
9. Conservation International gets support from Dreamworks Animation to protect giant pandas
10. AACR to host Seventh Annual International Conference on Frontiers in Cancer Prevention Research
11. Engineer to present leak-proof method for carbon dioxide storage at international conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
International Conference on Biotherapy to be held in the US
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... CA (PRWEB) , ... February 24, 2017 , ... Delpor, ... a $224K grant from the National Institute of Mental Health (NIMH) for the further ... on Delpor’s PROZOR technology and is expected to deliver therapeutic levels of ...
(Date:2/24/2017)... -- Symic Bio, a biopharmaceutical company focused on matrix ... announced today the completion of enrollment for the SHIELD ... trial will evaluate the safety and efficacy of SB-030, ... restenosis following angioplasty. "We,re pleased to ... Nathan Bachtell , M.D., Chief Medical Officer of ...
(Date:2/24/2017)... 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China ... company in China, today announced its financial results for the ... Fourth Quarter 2016 Financial Highlights Total ... in RMB terms, or increased by 13.6% in USD terms ... of 2015. Gross profit increased by 13.3% ...
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
Breaking Biology Technology: